Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M. L. Clements-Mann"'
Autor:
B. Graham, R. El Habib, G. Gorse, Steffanie Sabbaj, Kent J. Weinhold, A. M. Duliege, Paul A. Goepfert, T. Evans, B. Savarese, M. L. Clements-Mann, Carol Smith, C. Harrow, M. Greenberg, Lawrence Corey, David A. Schwartz, David C. Montefiori, M. Klein, J. McElrath, Don Stablein, S. Frey, R. Dolin, J. L. Excler, M. Grabowsky, M. Keefer, P. Spearman, P. Wright, M. C. Walker, R. Belshe, M. Wolff, M. Mulligan
Publikováno v:
The Journal of infectious diseases. 183(4)
Elicitation of both memory cytotoxic T cell responses and human immunodeficiency virus (HIV)-neutralizing antibodies are desirable characteristics of an HIV vaccine regimen. We studied a combination vaccine regimen consisting of a canarypox (CP) vect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc1698ac17dbf19e7310c7fbc01bfd1
https://pubmed.ncbi.nlm.nih.gov/11170981
https://pubmed.ncbi.nlm.nih.gov/11170981
Autor:
M L, Clements-Mann, M K, Makhene, J, Mrukowicz, P F, Wright, Y, Hoshino, K, Midthun, E, Sperber, R, Karron, A Z, Kapikian
Publikováno v:
Vaccine. 17(20-21)
Live rotavirus vaccine candidates representing VP7 serotypes 1, 2, 3 or 4 derived by reassortment between bovine UK rotavirus and human rotavirus strains D, DS-1, P or ST3 were evaluated for safety and immunogenicity in adults, children and infants.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::56546180e5670aa45bd382968c7021eb
https://pubmed.ncbi.nlm.nih.gov/10418923
https://pubmed.ncbi.nlm.nih.gov/10418923
Autor:
M L, Clements-Mann
Publikováno v:
AIDS research and human retroviruses. 14
Critical misconceptions about vaccine development have arisen in the context of acquired immunodeficiency syndrome (AIDS) vaccine research. These include: the goal of vaccination; the biological relevance and predictive value of animal models; the me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f73268931478a0f728ace0cfc286130
https://pubmed.ncbi.nlm.nih.gov/9814944
https://pubmed.ncbi.nlm.nih.gov/9814944
Autor:
M L, Clements-Mann, K, Weinhold, T J, Matthews, B S, Graham, G J, Gorse, M C, Keefer, M J, McElrath, R H, Hsieh, J, Mestecky, S, Zolla-Pazner, J, Mascola, D, Schwartz, R, Siliciano, L, Corey, P F, Wright, R, Belshe, R, Dolin, S, Jackson, S, Xu, P, Fast, M C, Walker, D, Stablein, J L, Excler, J, Tartaglia, E, Paoletti
Publikováno v:
The Journal of infectious diseases. 177(5)
A safety and immunogenicity trial was conducted in vaccinia-immune and vaccinia-naive human immunodeficiency virus (HIV)-uninfected adults who were randomized to receive 10(6) or 10(7) TCID50 of canarypox (ALVAC) vector expressing HIV-1MN gp160 or 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9f9b97774000d2e924491a89597fbbd
https://pubmed.ncbi.nlm.nih.gov/9593008
https://pubmed.ncbi.nlm.nih.gov/9593008
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 28:561
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ccb81378dd970507c6b14bc25b1aa8f
https://doi.org/10.1097/00005176-199905000-00092
https://doi.org/10.1097/00005176-199905000-00092
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 28:561
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::067b1ed27eaf31180f1a78abebefc7ae
https://doi.org/10.1097/00005176-199905000-00091
https://doi.org/10.1097/00005176-199905000-00091